# Disc Medicine Shares APOLLO Trial Results

> Disc Medicine CEO reveals bitopertin trial success for EPP patients.
- Title: Disc Medicine Shares APOLLO Trial Results · Seekingalpha
- Summary: Disc Medicine CEO reveals bitopertin trial success for EPP patients. Disc Medicine reported positive top-line results from APOLLO Phase III trial of…
- Keywords: disc medicine, iron, bitopertin, epp, apollo phase iii, clinical trial, money, business, Disc, Medicine, Shares, APOLLO
- Source: Seekingalpha — https://seekingalpha.com/article/4955208-disc-medicine-inc-iron-discusses-topline-results-of-apollo-phase-iii-trial-of-bitopertin-in
- Author: SA Transcripts
- Published: 2026-10-19T19:53:59+00:00
- Read time: 1 min
- Topics: disc medicine, iron, bitopertin, epp, apollo phase iii, clinical trial, money, business
## Company Announces Trial Results
Disc Medicine shares top-line results from APOLLO Phase III trial of bitopertin for erythropoietic protoporphyria.
## CEO Discusses Findings
John Quisel, CEO, states the trial results are positive for patients with erythropoietic protoporphyria.
## Next Steps for Treatment
Disc Medicine plans to discuss further data and potential regulatory submissions following the trial results.
## Key takeaway

Disc Medicine reported positive top-line results from APOLLO Phase III trial of bitopertin for erythropoietic protoporphyria.